ALIQOPA (copanlisib) for injection, for intravenous use Initial U.S. Approval: 2017. Available In India.

ALIQOPA (copanlisib) for Injection suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of ALIQOPA (copanlisib) for Injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the ALIQOPA (copanlisib) for Injection medicine cost price in India.

The order for ALIQOPA (copanlisib) for Injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Copanlisib (trade name Aliqopa codenamed BAY 80-6946) is a drug which is approved by US FDA for the treatment of adult patients experiencing relapsed follicular lymphoma who have received at least two prior systemic therapies.

ALIQOPA (copanlisib) for injection, for intravenous use. Initial U.S. Approval: 2017

Generic Name: Copanlisib

For injection: 60 mg as a lyophilized solid in single-dose vial for reconstitution